ATRC insider buying and SEC filings, explained
AtriCure, Inc. · CIK 1323885
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$2.2M
Planned sales (10b5-1)
$880K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 23, 2026 | Planned (10b5-1) | Salvatore Privitera (Chief Technical Officer) sold 4,519 shares at $60.00 ($271K), marked as a 10b5-1 plan trade. Holdings down 3% to 142,745 shares. | SEC filing Filed Sep 24, 2026 |
| Sep 11, 2026 | Sale | Regina E. Groves (Director) sold 5,313 shares at about $54.22 ($288K). Holdings down 13% to 34,546 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 14, 2026 |
| Sep 8, 2026 | Planned (10b5-1) | Salvatore Privitera (Chief Technical Officer) sold 3,657 shares at $55.00 ($201K), marked as a 10b5-1 plan trade. Holdings down 2% to 147,264 shares. | SEC filing Filed Sep 10, 2026 |
| Sep 2, 2026 | Planned (10b5-1) | Salvatore Privitera (Chief Technical Officer) sold 7,763 shares at $52.50 ($408K), marked as a 10b5-1 plan trade. Holdings down 5% to 150,921 shares. | SEC filing Filed Sep 4, 2026 |
| Aug 24, 2026 | Sale | Karl S. Dahlquist (Chief Legal Officer) sold 9,370 shares at about $48.89 ($458K). Holdings down 10% to 87,319 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 26, 2026 |
| Aug 5, 2026 | Sale | Maggie Yuen (Director) sold 3,500 shares at about $38.42 ($134K). Holdings down 20% to 14,015 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 5, 2026 | Sale | Karen Prange (Director) sold 3,564 shares at $38.80 ($138K). Holdings down 14% to 22,809 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Jul 29, 2026 | Sale | Justin J Noznesky (Chief Mktg & Strategy Officer) sold 6,182 shares at about $38.80 ($240K). Holdings down 6% to 100,219 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| Jul 28, 2026 | Sale | Vinayak Doraiswamy (Chief Scientific Officer) sold 6,000 shares at about $38.88 ($233K). Holdings down 6% to 86,511 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 30, 2026 |
| May 20, 2026 | Sale | Karen Prange (Director) sold 3,000 shares at about $28.65 ($86K). Holdings down 10% to 26,373 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 22, 2026 |
| May 15, 2026 | Sale | Vinayak Doraiswamy (Chief Scientific Officer) sold 5,000 shares at $28.13 ($141K). Holdings down 5% to 91,875 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 18, 2026 |
| Mar 12, 2026 | Sale | Vinayak Doraiswamy (Chief Scientific Officer) sold 5,000 shares at about $29.83 ($149K). Holdings down 5% to 96,875 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 16, 2026 |
| Nov 26, 2025 | Sale | Justin J Noznesky (Chief Mktg & Strategy Officer) sold 5,166 shares at about $37.29 ($193K). Holdings down 6% to 78,798 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 26, 2025 |
| Nov 21, 2025 | Sale | Maggie Yuen (Director) sold 3,000 shares at about $35.72 ($107K). Holdings down 21% to 11,371 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 25, 2025 |
30 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 4:00 PM ET 8-K | Earnings released (Item 2.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ATRC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.